Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.25 | N/A |
| PEG Ratio (TTM) | 0.53 | N/A |
| P/S Ratio (TTM) | 1.56 | N/A |
| P/B Ratio (TTM) | 2.28 | N/A |
| P/FCF Ratio (TTM) | 7.01 | N/A |
| Price to 5YR AVG Earnings Ratio | -5.21 | N/A |
| Price to 5YR AVG FCF Ratio | 10.30 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.51% | N/A |
| ROE (TTM) | 7.95% | N/A |
| Net Profit Margin (TTM) | 5.46% | N/A |
| ROIC 5YR AVG | 13.00% | N/A |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 351.91% | -430.30% | -111.12% |
| Revenue | 0.76% | -1.41% | 1.21% |
| Net Income | 352.84% | -410.01% | -103.75% |
| Cash Flow | 17.04% | -0.60% | -0.46% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.79 | N/A |
| Quick Ratio (TTM) | 1.79 | N/A |
| D/E Ratio (TTM) | 0.93 | N/A |
| Interest Coverage (TTM) | 1.49 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.83 | N/A |
| LTL to 5YR AVG FCF | 4.22 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.01% | N/A |